ImmunoGen
Stock Forecast, Prediction & Price Target
ImmunoGen Financial Estimates
ImmunoGen Revenue Estimates
ImmunoGen EBITDA Estimates
ImmunoGen Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $132.29M N/A | $108.78M -17.77% | $108.78M 0% | Avg: $538.20M Low: $375.24M High: $607M avg. 394.75% | Avg: $757.20M Low: $628.21M High: $900.72M avg. 40.69% | ||
Net Income
% change YoY
| $-66.68M N/A | $-222.92M -234.31% | $-222.92M 0% | Avg: $104.14M Low: $45.65M High: $142.03M avg. 146.71% | Avg: $258.47M Low: $98.91M High: $410.88M avg. 148.18% | ||
EBITDA
% change YoY
| $-19.68M N/A | $-217.54M -1005.24% | $-217.54M 0% | Avg: $-424.92M Low: $-296.26M High: $-479.24M avg. -95.32% | Avg: $-597.83M Low: $-496.00M High: $-711.15M avg. -40.69% | ||
EPS
% change YoY
| -$0.38 N/A | -$0.88 -131.57% | -$0.88 0% | Avg: $0.35 Low: $0.18 High: $0.56 avg. 139.59% | Avg: $0.86 Low: $0.39 High: $1.62 avg. 145.46% | ||
Operating Expenses
% change YoY
| $153.19M N/A | $329.49M 115.08% | $329.49M 0% | Avg: $330.35M Low: $230.32M High: $372.57M avg. 0.25% | Avg: $464.77M Low: $385.60M High: $552.87M avg. 40.69% | ||
FAQ
What is ImmunoGen stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 147.45% in 2025-2026.
We have gathered data from 11 analysts. Their low estimate is 45.65M, average is 104.14M and high is 142.03M.
What is ImmunoGen stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 217.72% in 2025-2026.
We have gathered data from 11 analysts. Their low revenue estimate is $375.24M, average is $538.20M and high is $607M.
What is ImmunoGen stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 142.52% in 2025-2026.
We have gathered data from 11 analysts. Their low earnings per share estimate is $0.18, average is $0.35 and high is $0.56.
What is the best performing analyst?
In the last twelve months analysts have been covering ImmunoGen stock. The most successful analyst is Brian Cheng whose win rate is 100%. He has correctly predicted 1/1 price targets.